Skip to content

Tivdak

Published: July 26, 2026Updated: August 25, 2026

Tivdak is a brand-name antibody-drug conjugate used to treat recurrent or metastatic cervical cancer in adult patients whose disease has progressed after chemotherapy. It works by targeting and binding to cancer cells, delivering a cytotoxic agent directly to them to help stop tumor growth and spread.

Quick summary

Tivdak is a targeted cancer therapy for adults with recurrent or metastatic cervical cancer that has progressed following chemotherapy treatment.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

RxNorm
2571100
Generic
Tivdak
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Tivdak is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer who have experienced disease progression on or after chemotherapy. It is typically used when the cancer has spread to other parts of the body or has returned after initial treatment.

Tivdak is an antibody-drug conjugate (ADC) that consists of a monoclonal antibody linked to a cytotoxic agent. The antibody portion targets and binds to tissue factor, a protein found on the surface of certain cancer cells. Once bound, the medication delivers the cytotoxic agent directly into the cancer cell, where it interferes with cell division and growth, leading to cell death.

Tivdak is administered by intravenous (IV) infusion. Common side effects may include fatigue, nausea, peripheral neuropathy, and bleeding. As it is a targeted therapy with a cytotoxic component, healthcare providers will monitor patients closely during treatment. Patients should discuss all medications and health conditions with their doctor before starting treatment, and report any unusual symptoms or side effects promptly.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy